These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16079263)

  • 41. A newly discovered TSHR variant (L665F) associated with nonautoimmune hyperthyroidism in an Austrian family induces constitutive TSHR activation by steric repulsion between TM1 and TM7.
    Jaeschke H; Schaarschmidt J; Eszlinger M; Huth S; Puttinger R; Rittinger O; Meiler J; Paschke R
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2051-9. PubMed ID: 24947036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substitutions of tyrosine 601 in the human thyrotropin receptor result in increase or loss of basal activation of the cyclic adenosine monophosphate pathway and disrupt coupling to Gq/11.
    Arseven OK; Wilkes WP; Jameson JL; Kopp P
    Thyroid; 2000 Jan; 10(1):3-10. PubMed ID: 10691307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new phenotype of nongoitrous and nonautoimmune hyperthyroidism caused by a heterozygous thyrotropin receptor mutation in transmembrane helix 6.
    Winkler F; Kleinau G; Tarnow P; Rediger A; Grohmann L; Gaetjens I; Krause G; L'Allemand D; Grüters A; Krude H; Biebermann H
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3605-10. PubMed ID: 20501679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations of thyrotropin receptor gene.
    Porcellini A; Fenzi G; Avvedimento EV
    J Mol Med (Berl); 1997 Aug; 75(8):567-75. PubMed ID: 9297624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of thyrotropin receptor germline mutations and clinical courses in 89 hyperthyroid patients with diffuse goiter and negative anti-thyrotropin receptor antibodies.
    Nishihara E; Fukata S; Hishinuma A; Amino N; Miyauchi A
    Thyroid; 2014 May; 24(5):789-95. PubMed ID: 24279482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma.
    Cordella D; Muzza M; Alberti L; Colombo P; Travaglini P; Beck-Peccoz P; Fugazzola L; Persani L
    Endocr Relat Cancer; 2006 Sep; 13(3):945-53. PubMed ID: 16954442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The TSH receptor and thyroid diseases.
    Paschke R; Van Sande J; Parma J; Vassart G
    Baillieres Clin Endocrinol Metab; 1996 Jan; 10(1):9-27. PubMed ID: 8734449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activating mutations of TSH receptor.
    Rodien P; Ho SC; Vlaeminck V; Vassart G; Costagliola S
    Ann Endocrinol (Paris); 2003 Feb; 64(1):12-6. PubMed ID: 12707626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism.
    Camacho P; Gordon D; Chiefari E; Yong S; DeJong S; Pitale S; Russo D; Filetti S
    Thyroid; 2000 Nov; 10(11):1009-12. PubMed ID: 11128715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.
    Führer D; Wonerow P; Willgerodt H; Paschke R
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4234-8. PubMed ID: 9398746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatic and germline mutations of the TSH receptor and thyroid diseases.
    Corvilain B; Van Sande J; Dumont JE; Vassart G
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):143-58. PubMed ID: 11531919
    [No Abstract]   [Full Text] [Related]  

  • 52. A family with a novel TSH receptor activating germline mutation (p.Ala485Val).
    Akcurin S; Turkkahraman D; Tysoe C; Ellard S; De Leener A; Vassart G; Costagliola S
    Eur J Pediatr; 2008 Nov; 167(11):1231-7. PubMed ID: 18175146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activating mutations of the TSH receptor gene cause thyroid diseases.
    Vassart G; Van Sande J; Parma J; Tonacchera M; Duprez L; Swillens S; Dumont J
    Ann Endocrinol (Paris); 1996; 57(1):50-4. PubMed ID: 8734289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH.
    Russo D; Betterle C; Arturi F; Chiefari E; Girelli ME; Filetti S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4238-42. PubMed ID: 11095460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A somatic point mutation in a putative ligand binding domain of the TSH receptor in a patient with autoimmune hyperthyroidism.
    Heldin NE; Gustavsson B; Westermark K; Westermark B
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1374-6. PubMed ID: 1955520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene.
    Kopp P; van Sande J; Parma J; Duprez L; Gerber H; Joss E; Jameson JL; Dumont JE; Vassart G
    N Engl J Med; 1995 Jan; 332(3):150-4. PubMed ID: 7800007
    [No Abstract]   [Full Text] [Related]  

  • 58. Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism.
    Gozu HI; Lublinghoff J; Bircan R; Paschke R
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):125-34. PubMed ID: 20138963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New pathophysiological mechanisms for hyperthyroidism.
    Vassart G
    Horm Res; 1997; 48 Suppl 4():47-50. PubMed ID: 9350447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy.
    Kraemer S; Rothe K; Pfaeffle R; Fuehrer-Sakel D; Till H; Muensterer OJ
    J Pediatr Endocrinol Metab; 2009 Mar; 22(3):269-74. PubMed ID: 19492584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.